Webinar information
Carrier screening to assess reproductive risk is becoming increasingly common in medical practice and enables patients to make informed decisions about their reproductive options. In 2021, the American College of Medical Genetics and Genomics (ACMG) released a practice guideline recommending a consistent approach to carrier screening for reproductive decision making. In this webinar, we will explore the rationale for offering carrier screening and things to consider when selecting a test. We will also discuss points to cover as part of the pre-test and post-test counseling and will conclude with some case examples.
Webinar objectives
- Introduce carrier screening for reproductive risk and points to consider when choosing a test
- Outline topics for pre- and post-test counselling related to carrier screening
- Review experiences with x carrier screening through case examples
Blueprint Genetics does not offer screening tests in the US at this time.
Unable to attend live? By registering, you will receive a link to a recording of the webinar for you to watch at your convenience
Speakers
Allison Sluyters
Allison Sluyters, MSc, CCGC, CGC is a clinical genomic liaison at Blueprint Genetics. She received her Bachelor of Science from the University of Western Ontario and her Master of Science in Genetic Counseling from the University of Toronto. She is certified by the both the American Board of Genetic Counsellors and the Canadian Board of Genetic Counsellors. Prior to joining Blueprint Genetics in 2019, she worked in clinical practice for over 10 years and as a laboratory genetic counselor for her local laboratory. Allison and her family also had the amazing opportunity to spend a year in New Zealand where she worked as a genetic counselor and regional coordinator for the New Zealand Familial Gastrointestinal Cancer Service.
Lotta Koskinen
Lotta Koskinen is an associate laboratory director with a focus on production and scientific activities. She collaborates with laboratory and genetics directors, and managers and leads in maintaining and developing variant assessment and reporting processes. She also helps to plan and introduce new products. She also coordinates scientific support for Clinical Genomic Services (CGS) and Client Services in their questions related interpretation and reports. Lotta has MSc degree in genetics and received her PhD in medical genetics from the University of Helsinki, Finland in 2009. After post-doctoral training in academic genetics laboratories, she joined Blueprint Genetics in 2017. Prior to her current position, she worked as a geneticist in panel and WES interpretation, and as a manager in the Clinical Interpretation Team at Blueprint Genetics.